Norge -
norsk -
Statens legemiddelverk
levomepromazine orion 100 mg
orion corporation - espoo - levomepromazinmaleat - tablett - 100 mg
Norge -
norsk -
Statens legemiddelverk
levomepromazine orion 25 mg
orion corporation - espoo - levomepromazinmaleat - tablett - 25 mg
Norge -
norsk -
Statens legemiddelverk
nozinan 25 mg
mylan healthcare norge as - levomepromazinhydroklorid - tablett, drasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
nozinan 5 mg
meda as - levomepromazinhydroklorid - tablett, drasjert - 5 mg
Norge -
norsk -
Statens legemiddelverk
nozinan 100 mg
mylan healthcare norge as - levomepromazinhydroklorid - tablett, drasjert - 100 mg
Norge -
norsk -
Statens legemiddelverk
tranquinervin vet 10 mg/ ml
le vet beheer b.v. - acepromazinmaleat - injeksjonsvæske, oppløsning - 10 mg/ ml
Norge -
norsk -
Statens legemiddelverk
tranquigel vet 35 mg/ g
le vet beheer b.v. - acepromazinmaleat - oralgel - 35 mg/ g
Norge -
norsk -
Statens legemiddelverk
plegicil vet 35 mg/ ml
floris holding bv - acepromazinmaleat - oralgel - 35 mg/ ml
Norge -
norsk -
Statens legemiddelverk
sedanine vet 35 mg/ ml
floris veterinaire produkten bv - acepromazinmaleat - oralgel - 35 mg/ ml
Den europeiske union -
norsk -
EMA (European Medicines Agency)
orfadin
swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).